Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatment of schizophrenia in acute care inpatient settings

By Mladsi Deirdre M.   Grogg Amy L.   Irish William D.   Lopez Rebecca B.   Degen Kathleen   Swann Alan   Nimsch Christian T.  

Current Medical Research and Opinion, Vol. 20, Iss. 12, 2004-12 ,pp. : 1883-1893

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness of olanzapine vs. aripiprazole in the treatment of schizophrenia

By Ascher-Svanum Haya   Stensland Michael D.   Peng Xiaomei   Faries Douglas E.   Stauffer Virginia L.   Osuntokun Olawale O.   Kane John M.  

Current Medical Research and Opinion, Vol. 27, Iss. 1, 2011-01 ,pp. : 115-122

Informa Healthcare

Access to resources Recommend Favorite

Population pharmacokinetic modeling of quetiapine after administration of seroquel and seroquel XR formulations to Western and Chinese patients with schizophrenia, schizoaffective disorder, or bipolar disorder

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 91-2700, Iss. 11, 2015-11 ,pp. : 1248-1255

John Wiley & Sons Inc

Access to resources Recommend Favorite

Population pharmacokinetic modeling of quetiapine after administration of seroquel and seroquel XR formulations to Western and Chinese patients with schizophrenia, schizoaffective disorder, or bipolar disorder

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 11, 2015-11 ,pp. : 1248-1255

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials

By Buckley Peter F.  

Current Medical Research and Opinion, Vol. 20, Iss. 9, 2004-09 ,pp. : 1357-1363

Informa Healthcare

Access to resources Recommend Favorite